Delivery Order SPE2DB25D3012-SPE2DB25FXAGP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on September 12, 2025, with a contract ceiling value of $3,769.60 and an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed pricing and represents a pharmaceutical supply transaction to support federal medical procurement needs. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Progesterone 200 mg capsules (100 count) with a ceiling value of $6,136.78. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units. This firm fixed-price delivery order, valued at $10,748.99, is scheduled for completion by September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis through competitive procurement procedures, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $32,993.69. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside award made through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $14,441.36 and carries no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract value of $2,651.34. This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and represents work to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation applied. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Progesterone 200 mg capsules (100 count) with a ceiling value of $4,508.52. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside contract vehicle, with an ultimate completion date of August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $3,562.06. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $14,885.28. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $30,912.13. This firm fixed-price delivery order, which is expected to be completed by August 15, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting the...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAGPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $13,427.04. This non-set-aside delivery order is scheduled for ultimate completion on September 19, 2025, with performance conducted from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the company's critical role as a pharmaceutical distributor supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The company's consistent selection through competitive awards reflects its capability to meet federal pharmaceutical supply requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 9/18/25 |